To Evaluate the Efficacy and Safety of Gefitinib in Adjuvant Chemotherapy for Lung Adenocarcinoma
Condition(s):NSCLC; EGFRLast Updated:September 4, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):NSCLC; EGFRLast Updated:September 4, 2018Unknown status
Condition(s):Carcinoma, Non-Small-Cell Lung; AdenocarcinomaLast Updated:April 6, 2018Completed
Condition(s):Cryptococcosis; Lung AdenocarcinomaLast Updated:September 18, 2020Unknown status
Condition(s):Lung Adenocarcinoma; Colon AdenocarcinomaLast Updated:February 10, 2021Completed
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:October 31, 2016Completed
Condition(s):Pulmonary CancerLast Updated:June 29, 2010Completed
Condition(s):Adenocarcinoma of the LungLast Updated:February 6, 2024Completed
Condition(s):Advanced Non-small Cell Lung CancerLast Updated:October 3, 2023Active, not recruiting
Condition(s):Lung Cancer; NSCLC; NSCLC AdenocarcinomaLast Updated:September 5, 2017Terminated
Condition(s):Non-small Cell Lung Cancer(NSCLC)Last Updated:January 15, 2014Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.